← Leaderboards
Emily Elizabeth Marshall
Tomegavax, Inc.
$412,171
Attributed
$524,506
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $299.8K · FY2012–14$500K$375K$250K$125K$0
'12
'13
'14
Funding mix
By agency
NIH$524,506 · 2
By mechanism
R43$524,506 · 2
Top collaborators
- Eric Bruening1 shared
Others in their field
Top investigators on “Prophylactic”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$188,118,721
- J Brooks Jackson · Social And Scientific Systems, Inc.$151,807,671
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$95,724,261
- Sharon A Nachman · Johns Hopkins University$74,930,519
- Deborah J Donnell · Fred Hutchinson Cancer Center$58,830,942
Research focus
ProphylacticVaccinatedImmunogenicityPathogenSafetyT Memory CellImmuneImmunityMacaca MulattaNovel VaccinesRecombinantsReconstitutionT Cell ResponseTherapeutic VaccineAnimalsCytomegalovirusBaseCharacteristicsInfectionInnovationMalignant NeoplasmsNonhuman PrimateAntigensVaccines